Get the live share price of Natera Inc (NTRA), including intraday charts, historical performance, key financials, and market ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the launch of Natera’s ...

Over the past six months, Natera has been a great trade, beating the S&P 500 by 24.2%. Its stock price has climbed to $235.65, representing a healthy 37.1% increase. This was partly thanks to its ...

If you are wondering whether Natera's share price still makes sense after such a big run, you are not alone. This breakdown is designed to help you decide if the current price offers genuine value or ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA ...

The company has a platform for cell-free DNA testing for prenatal tests, cancer diagnostics and rejection assessments for ...

Natera, Inc. , a global leader in cell-free DNA and precision medicine, today announced that new data from the ALTAIR trial will be presented at the 2026 American Society of Clinical Oncology ...

NeoGenomics, Inc. , a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the Company will participate in the upcoming 44th Annual J.P. Morgan Healthcare ...

Cathie Wood’s latest moves entering 2026 focused on early-stage biotechnology firms while cutting exposure to consumer ...

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, ...

Looking back at the performance of ARK Invest, led by Cathie Wood (“Cathie Wood”), in 2025, despite reducing its holdings of Tesla (TSLA) by over 633,000 shares during the ...